-
2023-507357-15-00
6
Dry Eye Disease
-
2023-507357-15-01
6
Dry Eye Disease
-
2024-518237-28-00
6
recurrence of acute biliary pancreatitis
-
2024-519673-18-00
4
Patients with localized renal cell carcinoma
-
2024-520020-28-00
7
Cytomegalovirus infection post allogeneic allogeneic HLA-identical fam
-
2024-520336-14-00
5
Post-chemotherapy neutropenia with high risk of developing infection i
-
2025-520554-11-00
5
Cardiovascular Disease
-
2025-520937-22-00
4
advanced chronic ischemia (fontaine III-IV class and Rutherford IV-V),
-
2025-522373-10-00
5
Progressive pulmonary fibrosis and Idiopathic pulmonary fibrosis
-
2025-522818-23-00
5
Small Cell Lung Cancer (SCLC)
-
2025-523525-17-00
9
Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma
-
2025-524454-34-00
11
Bronchiectasis
-
2025-524488-18-00
4
Muscle-invasive Bladder Cancer
-
2025-524810-28-00
5
2026-07-02
Acute Promyelocytic Leukemia
-
2025-522267-15-00
10
2026-06-24
Relapsed/refractory B-cell Acute Lymphoblastic Leukemia
-
2025-522406-20-00
9
2026-06-15
Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
-
2024-518615-19-00
5
2026-04-22
Major Depressive Disorder
-
2025-522145-21-00
5
2026-04-13
Metastatic hormone sensitive prostate cancer
-
2025-522279-27-00
5
2026-04-02
Newly Diagnosed AML with an NPM1 mutation
-
2025-522892-27-00
4
2026-03-21
Bronchiectasis
-
2025-521314-25-00
5
2026-03-19
NPM1-m and KMT2A-r Acute Myeloid Leukemia
-
2024-519068-42-00
10
2026-02-12
Heterozygous Familial Hypercholesterolemia in pediatric patients
-
2024-518777-34-00
5
2026-02-11
B7-H4-Selected Advanced/Metastatic Endometrial Cancer.
-
2025-521919-39-00
3
2026-02-10
Resected stage IIB, IIC, or III melanoma requiring adjuvant treatment